Rather than rely on plant-derived products, biotech companies are engineering bacteria and yeast to produce ingredients for fragrances.
Daily News Roundup
Rather than rely on plant-derived products, biotech companies are engineering bacteria and yeast to produce ingredients for fragrances.
Researchers engineer a member of the insect's intestinal flora to help thwart the malaria parasite before it can infect new hosts.
Peptides extracted from scorpion venom fights off drug-resistant bacterial infections in mice.
Wales creates a database of DNA barcodes for all of its native flowering plants, hoping to guide conservation and drug development efforts.
The settings of programmable shunt devices used to treat brain swelling in children can be altered by magnetic fields, such as those given off by the Apple iPad 2.
Researchers in the U.K. are looking to breed marijuana to make medicines for metabolic disorders, epilepsy, and other diseases.
Researchers pull viable cells from bodies that had been dead for more than 2 weeks.
The criminal charges that had been brought upon chronic fatigue syndrome researcher Judy Mikovits for stealing data from her former employer have been dropped.
A United Kingdom ethics council approves altering human egg cells, which could allow doctors to correct mitochondrial disease in IVF patients.
For the first time, an oral cholera vaccine is used to control an active epidemic of the bacterial disease.